Please use this identifier to cite or link to this item: https://hdl.handle.net/1/1914
Title: sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance
Authors: Chan, Matthew M K ;Kaur, A.;Webster, M.R.;Marchbank, K.;Behera, R.;Ndoye, A.;Kugel 3rd, C.H.;Dang, V.M.;Appleton, J.;O'Connell, M.P.;Cheng, P.;Valiga, A.A.;Morissette, R.;McDonnell, N.B.;Ferrucci, L.;Kossenkov, A.V.;Meeth, K.;Tang, H.Y.;Yin, X.;Wood 3rd, W.H.;Lehrmann, E.;Becker, K.G.;Flaherty, K.T.;Frederick, D.T.;Wargo, J.A.;Cooper, Z.A.;Tetzlaff, M.T.;Hudgens, C.;Aird, K.M.;Zhang, R.;Xu, X.;Liu, Q.;Bartlett, E.;Karakousis, G.;Eroglu, Z.;Lo, R.S.;Menzies, A.M.;Long, G.V.;Johnson, D.B.;Sosman, J.;Schilling, B.;Schadendorf, D.;Speicher, D.W.;Bosenberg, M.;Ribas, A.;Weeraratna, A.T.
Issue Date: Apr-2016
Source: Volume 532, Issue 7598, pp. 250 - 254
Journal title: Nature
Abstract: Cancer is a disease of ageing. Clinically, aged cancer patients tend to have a poorer prognosis than young. This may be due to accumulated cellular damage, decreases in adaptive immunity, and chronic inflammation. However, the effects of the aged microenvironment on tumour progression have been largely unexplored. Since dermal fibroblasts can have profound impacts on melanoma progression, we examined whether age-related changes in dermal fibroblasts could drive melanoma metastasis and response to targeted therapy. Here we find that aged fibroblasts secrete a Wnt antagonist, sFRP2, which activates a multi-step signalling cascade in melanoma cells that results in a decrease in β-catenin and microphthalmia-associated transcription factor (MITF), and ultimately the loss of a key redox effector, APE1. Loss of APE1 attenuates the response of melanoma cells to DNA damage induced by reactive oxygen species, rendering the cells more resistant to targeted therapy (vemurafenib). Age-related increases in sFRP2 also augment both angiogenesis and metastasis of melanoma cells. These data provide an integrated view of how fibroblasts in the aged microenvironment contribute to tumour progression, offering new possibilities for the design of therapy for the elderly.
URI: https://elibrary.cclhd.health.nsw.gov.au/cclhdjspui/handle/1/1914
DOI: 10.1038/nature17392
Pubmed: https://pubmed.ncbi.nlm.nih.gov/27042933/
ISSN: 0028-0836
Publicaton type: Journal Article
Keywords: Cancer
Appears in Collections:Oncology / Cancer

Show full item record

Page view(s)

2
checked on Feb 2, 2023

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.